PHARMOS made a net profit of CZK 11.2 mil in 2019, up 128% compared to the previous year. Total sales reached CZK 10,337 mil, which is up 1.62% when compared to the previous year.
Historically, between 2006 and 2019, the company’s net profit reached a high of CZK 44.3 mil in 2016 and a low of CZK -27.0 mil in 2012. Over the last decade the firm's net profit increased by an average of 10.8% a year.
Sales have fallen by 1.89% a year on average since 2009. They reached a high of CZK 14,215 mil in 2011 and a low of CZK 10,173 mil in 2018.
The company has been operating with an average EBITDA margin of 0.569% in the last 5 years and average net margin of 0.172%. The firm generated an average return on invested capital of 1.10% for its shareholders over the last five years.
You can see all the company’s data at PHARMOS profile, or you can download a report on the company in the report section.
Helgi Library 
